CSIMarket
 


Genomic Health Inc  (GHDX)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

GHDX's Free Cash Flow Growth by Quarter and Year

Genomic Health Inc's Free Cash Flow results by quarter and year




GHDX Free Cash Flow (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - 24.58 9.14 11.61
III Quarter September 32.17 29.75 9.57 7.19
II Quarter June 38.38 15.96 11.12 -5.35
I Quarter March -3.67 6.28 0.77 -2.19
FY   66.88 76.57 30.60 11.26



GHDX Free Cash Flow third quarter 2019 Y/Y Growth Comment
Genomic Health Inc achieved in the third quarter 2019, above Company average Free Cash Flow improvement of 8.12% year on year, to $ 32.17 millions.

Looking into third quarter 2019 results within Medical Laboratories industry 6 other companies have achieved higher Free Cash Flow growth. While Genomic Health Inc' s Free Cash Flow increase of 8.12% ranks overall at the positon no. 934 in the third quarter 2019.




GHDX Free Cash Flow ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - 168.93 % -21.27 % 1016.35 %
III Quarter September 8.12 % 210.87 % 33.1 % -
II Quarter June 140.48 % 43.53 % - -
I Quarter March - 715.58 % - -
FY   - 150.23 % 171.76 % -

Financial Statements
Genomic Health Inc's third quarter 2019 Free Cash Flow $ 32.17 millions GHDX's Income Statement
Genomic Health Inc's third quarter 2018 Free Cash Flow $ 29.75 millions Quarterly GHDX's Income Statement
New: More GHDX's historic Free Cash Flow Growth >>


GHDX Free Cash Flow (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - -17.38 % -4.49 % 61.47 %
III Quarter September -16.19 % 86.4 % -13.94 % -
II Quarter June - 154.14 % 1344.16 % -
I Quarter March - -31.29 % -93.37 % -
FY (Year on Year)   - 150.23 % 171.76 % -




Free Cash Flow third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #7
Healthcare Sector #86
Overall #934

Free Cash Flow Y/Y Growth Statistics
High Average Low
96.78 % 6.61 % -50.11 %
(June 30. 2016)   (Sep. 30, 2014)
Free Cash Flow third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #7
Healthcare Sector #86
Overall #934
Free Cash Flow Y/Y Growth Statistics
High Average Low
96.78 % 6.61 % -50.11 %
(June 30. 2016)   (Sep. 30, 2014)

Free Cash Flow by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Genomic Health Inc's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
1353.73 % 110.68 % -100 %
(Jun 30 2017)  


GHDX's III. Quarter Q/Q Free Cash Flow Comment
In the III. Quarter 2019 Genomic Health Inc realized fall in Free Cash Flow from the second quarter by -16.19% to $ 32.17 millions, from $ 38.38 millions achived in the previous reporting period.

Those periodic circumstance which commonly energize III. Quarter 2019 performance, could not salvage the III. Quarter for the Genomic Health Inc, María Carmen Ortega, market observer from Madrid pointed out.

Within Medical Laboratories industry 8 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Genomic Health Inc's Free Cash Flow growth quarter on quarter, overall rank is 1197.


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #9
Healthcare Sector #88
Overall #1197
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #9
Healthcare Sector #88
Overall #1197
Free Cash Flow Q/Q Growth Statistics
High Average Low
1353.73 % 110.68 % -100 %
(Jun 30 2017)  


GHDX's III. Quarter Q/Q Free Cash Flow Comment
In the III. Quarter 2019 Genomic Health Inc disclosed fall in Free Cash Flow sequentially by -16.19% to $ 32.17 millions, from $ 38.38 millions achived in the previous quarter.

Although periodic influence which usually elevate III. Quarter 2019 Free Cash Flow, that clearly could not be substantial to salvage Medical Laboratories's company achievement, María Carmen Ortega, market observer from Madrid said and continued that average sequential Free Cash Flow growth is at 110.68% for Genomic Health Inc.

Within Medical Laboratories industry 8 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Genomic Health Inc's Free Cash Flow growth quarter on quarter, overall rank is 1197.


Genomic Health Inc's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
Cumulative Free Cash Flow 12 Months Ending $ 110.57 $ 105.14 $ 77.43 $ 86.64 $ 70.95
Y / Y Free Cash Flow Growth (TTM) 55.85 % 108.65 % 66.6 % 97.49 % 25.84 %
Year on Year Free Cash Flow Growth Overall Ranking # 267 # 184 # 375 # 218 # 889
Seqeuential Free Cash Flow Change (TTM) 5.16 % 35.79 % -10.63 % 22.12 % 40.79 %
Seq. Free Cash Flow Growth (TTM) Overall Ranking # 310 # 198 # 1987 # 363 # 382




Cumulative Free Cash Flow growth Comment
With the quarterly Free Cash Flow reported in the Sep 30 2019 period, Genomic Health Inc's cumulative twelve months Free Cash Flow were $ 111 millions, company would post below average annual Free Cash Flow growth of 40.79% year on year, if the fiscal year would end at Sep 30 2019.
A slow-down in the Genomic Health Inc's Free Cash Flow growth from the 38.38% growth in Jun 30 2019.

Within the Healthcare sector 22 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Free Cash Flow growth total ranking has deteriorated compare to previous quarter from 184 to 267.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
96.78 %
6.61 %
-50.11 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 3
Healthcare Sector # 23
Overall # 267

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
272.18 %
107.88 %
-8.55 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 25
S&P 500 # 310
Cumulative Free Cash Flow growth Comment
With the quarterly Free Cash Flow reported in the Sep 30 2019 period, Genomic Health Inc's cumulative twelve months Free Cash Flow were $ 111 millions, company would post below average annual Free Cash Flow growth of -8.55% year on year, if the fiscal year would end at Sep 30 2019.
A slow-down in the Genomic Health Inc's Free Cash Flow growth from the 38.38% growth in Jun 30 2019.

Within the Healthcare sector 22 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Free Cash Flow growth total ranking has deteriorated compare to previous quarter from 184 to 267.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
96.78 %
6.61 %
-50.11 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 3
Healthcare Sector # 23
Overall # 267

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
272.18 %
107.88 %
-8.55 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 25
S&P 500 # 310




Other Free Cash Flow Growth
Medical Laboratories Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
GHDX's Free Cash Flow Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for GHDX's Competitors
Free Cash Flow Growth for Genomic Health Inc's Suppliers
Free Cash Flow Growth for GHDX's Customers

You may also want to know
GHDX's Annual Growth Rates GHDX's Profitability Ratios GHDX's Asset Turnover Ratio GHDX's Dividend Growth
GHDX's Roe GHDX's Valuation Ratios GHDX's Financial Strength Ratios GHDX's Dividend Payout Ratio
GHDX's Roa GHDX's Inventory Turnover Ratio GHDX's Growth Rates GHDX's Dividend Comparisons



Companies with similar Free Cash Flow fall for the quarter ending Sep 30 2019 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Sep 30 2019
Celgene Corp12.89%$ 12.890 millions
Fonar Corporation12.58%$ 12.576 millions
Biospecifics Technologies Corp12.36%$ 12.357 millions
Repligen Corp11.61%$ 11.611 millions
Pediatrix Medical Group Inc 10.98%$ 10.982 millions
Pacira Biosciences inc 10.37%$ 10.373 millions
Lantheus Holdings Inc 8.92%$ 8.918 millions
Teleflex Incorporated8.67%$ 8.671 millions
Genomic Health Inc8.14%$ 8.136 millions
Globus Medical Inc 7.87%$ 7.874 millions
American Renal Associates Holdings Inc 7.73%$ 7.731 millions
Hologic Inc6.58%$ 6.583 millions
Heska Corporation6.18%$ 6.177 millions
Tivity Health Inc 6.01%$ 6.007 millions
Becton Dickinson And Company4.98%$ 4.977 millions
Masimo Corp4.61%$ 4.609 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com